Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrasers Group Regulatory News (FRAS)

Share Price Information for Frasers Group (FRAS)

Share Price is delayed by 15 minutes
Get Live Data
753.50    5.00 (0.67%)
Bid:
753.50
Ask:
756.00
Spread: 2.50 (0.332%)
Market Cap: £3.24b
FRAS Live PriceLast checked at - London Stock Exchange

Intraday Frasers Group Share Chart

Share Buyback Programme

20 Jun 2023 07:00

RNS Number : 2233D
Frasers Group PLC
20 June 2023
 

Date: 20 June 2023

 

Frasers Group Plc

("Frasers Group" or the "Company")

 

Share Buyback Programme

 

The Company announces that it has instructed Liberum Capital Limited in relation to a non-discretionary share buyback programme ("Programme") to purchase the Company's shares with effect from today's date for the period up to and including the last trading day prior to the publication of the Company's preliminary results for the financial year ended 30 April 2023. This replaces the share buyback programme for the period from today up to and including the last trading day prior to the publication of the Company's preliminary results for the financial year ended 30 April 2023 announced by the Company on 30 May 2023.

 

The aggregate purchase price of all shares acquired under the Programme will be no greater than £70,000,000. The maximum number of shares that may be purchased under the Programme will be 10,000,000 ordinary shares.

 

The purpose of the Programme is to reduce the share capital of the Company.

 

The Programme will be conducted within certain pre-set parameters, and in accordance with the general authority to repurchase shares granted by the Company's shareholders at the 2022 Annual General Meeting and Chapter 12 of the Financial Conduct Authority Listing Rules. A buy-back of ordinary shares on any trading day shall not exceed the 25% of the average daily trading volume specified in the provisions of the Market Abuse Regulation 596/2014/EU dealing with buyback programmes. The shares repurchased by the Company will be held in treasury pending cancellation or re-issue.

 

 

Ends.

 

 

Frasers Group plc

Robert Palmer, Company Secretary

LEI: 213800JEGHHEAXIJDX34

 

 

T. 0344 245 9200

E. company.secretary@frasers.group

 

Chris Wootton, Chief Financial Officer

 

T. 0344 245 9200

E. financial@frasers.group

 

 

Ronnie Laffar, Head of PR & Communications

 

 

T. 07585 886189

E. fgpr@frasers.group

 

 

Andrew Kasoulis, Head of Investor Relations

 

 

T. 0344 245 9200

E. investor.relations@frasers.group

 

 

Barclays Bank PLC, acting through its Investment Bank

 

Nicola Tennent

 

Stuart Muress

T. 020 7623 2323

 

Numis

 

Luke Bordewich

 

Stuart Ord

 

Ollie Steele

 

 

T. 020 7260 1000

 

Liberum

 

John Fishley

 

Edward Thomas

 

Kane Collings

 

Nikhil Varghese

 

 

T. 020 3100 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUKURROKUNAUR
Date   Source Headline
26th Feb 20247:00 amRNSDirectorate Change
23rd Feb 202411:30 amRNSHolding(s) in Company
22nd Feb 202412:05 pmRNSForm 8.3 - Currys plc
21st Feb 20243:40 pmRNSForm 8.3 -Currys PLC
21st Feb 20243:36 pmRNSForm 8.3 - Currys PLC
20th Feb 20245:15 pmRNSHolding(s) in Company
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 202412:30 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20248:32 amRNSNotification of Major Holdings
24th Jan 20242:53 pmRNSHolding(s) in Company
19th Jan 20249:00 amRNSDirector/PDMR Shareholding
18th Jan 202411:15 amRNSDirector/PDMR Shareholding
18th Jan 202410:14 amRNSHolding(s) in Company
18th Jan 20247:00 amRNSNotification of Major Holdings
17th Jan 20244:12 pmRNSHolding(s) in Company
16th Jan 20248:33 amRNSHolding(s) in Company
12th Jan 20243:40 pmRNSHolding(s) in Company
12th Jan 20243:39 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSAppointment of Joint Broker
10th Jan 20242:58 pmRNSHolding(s) in Company
2nd Jan 20242:05 pmRNSTotal Voting Rights
20th Dec 20234:34 pmRNSHolding(s) in Company
20th Dec 202310:41 amRNSAcquisition
20th Dec 20239:54 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
4th Dec 20237:00 amRNSNotification of Major Holdings
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20233:50 pmRNSBusiness Acquisition update
21st Nov 202311:19 amRNSHolding(s) in Company
7th Nov 20237:00 amRNSShare buyback programme
6th Nov 202311:50 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 202311:00 amRNSDirector/PDMR Shareholding - correction
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20236:30 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSDisposal
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSReplacement: Notification of Major Holdings
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in Own Shares
25th Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSNotification of Major Holdings
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
19th Oct 20231:01 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.